You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • FRI0219 Risk Factors of Severe Infections in Patients with Rheumatoid Arthritis Treated with Tocilizumab in The French Registry Regate (Registry –Roactemra)

Citation Tools

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - other biologic treatment
FRI0219 Risk Factors of Severe Infections in Patients with Rheumatoid Arthritis Treated with Tocilizumab in The French Registry Regate (Registry –Roactemra)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Morel J, Constantin A, Dernis E, et al
FRI0219 Risk Factors of Severe Infections in Patients with Rheumatoid Arthritis Treated with Tocilizumab in The French Registry Regate (Registry –Roactemra)
Annals of the Rheumatic Diseases 2016;75:511.